83% rally in six months: Why Nuvama expects 25% upside in this pharma stock
Laurus Labs, a multibagger pharma stock, has gained 416% in three years and 329% in two years.
Attribution
This digest is published with acknowledgment to Business Today. For the complete analysis, headnotes, and citations, please refer to the source.
Read on Business Today